Inventor · disambiguated record
Mark Semenuk
Also filed as: SEMENUK MARK
2 granted patents·5 pending applications·65 citations·filing 1988–2022
58Inventor score
Files withPANACEA PHARMACEUTICALS INC2PREC BIOLOGICS INC2ADI DIAGNOSTICS INC1DU XIULIAN1SEMENUK MARK1
Top patents by PatentIndex Score
7 records- 0164US11345733B2Colon and pancreas cancer specific antigens and antibodiesPREC BIOLOGICS INC·Filed 2018·Granted May 31, 2022·0 cites·19 claims
- 0264US2023032624A1Colon and pancreas cancer specific antigens and antibodiesPREC BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 0356US2021148915A9Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsPANACEA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0454US5000193AMedical swab deviceADI DIAGNOSTICS INC·Filed 1988·Granted Mar 19, 1991·65 cites·15 claims
- 0550US2016077098A1Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsSEMENUK MARK·Filed 2015·Application pending·0 cites
- 0642US2019049455A1HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when CombinedPANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0740US2013189268A1Colon and pancreas cancer specific antigens and antibodiesDU XIULIAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Semenuk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →